In recent years, the artificial organs market 2025 has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. This report is being written to illustrate the artificial organs market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current artificial organs market scenario and the way it will grow in future. Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and artificial organs market segment growth. The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews.
The increasing number of elderly people worldwide is making organ transplantation especially important. The number of people over 65 years of age receiving and seeking organ transplants is increasing. The demand for prosthetic devices is higher in the elderly population, as they are more susceptible to post-implantation side effects. According to HRSA, 8,895 organ transplant procedures were performed on people over the age of 65 in the US. in 2022. 42,887 organ transplants were performed in the US. in 2022, up from 2021 by 3.7 percent. So, with increasing age increasing demand organ donors increase the need for prosthetic devices.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/artificial-organs-market
Global artificial organs market segmental analysis
Analysis by Technology
The mechanical segment dominated the market with the highest revenue growth of 66.9% in 2022. This is due to higher organ failure and lower cost of mechanical bionics. Mechanical heart valve durability is significant when compared to other methods, resulting in strong demand. Other factors driving the growth include faster FDA approvals and reimbursement arrangements. For example, in September 2021, the FDA approved the Abbott Portico a FlexNav TAVR system for the treatment of individuals with symptomatic and diseased aortic stenosis who may be at high or very high risk for open heart surgery.
The electronics segment is expected to grow at the fastest CAGR of 9.9% during the forecast period. According to Bionics Queensland, there are approximately 1.0 billion people with physical disabilities, and 190 million adults with major functional challenges. In most developing countries, infrastructure and financial constraints remain high. For many people with disabilities, the only option is to receive prosthetic limbs. These exercisers are myoelectrically controlled battery-electronic systems and can stimulate muscles through sensors. These sensory electronics allow prosthetics to move. Machine learning, smart wearables and element modelling are being used to make progress. Also, increasing accidents, amputees and increasing number of limbless people are expected to drive the demand for electronic bionics.
Analysis by Product
The artificial organs segment dominated the market with a high revenue growth of 70.4% in 2022. The demand for kidney, heart, lung and liver transplants contributes to the average growth of this segment waiting for a kidney transplant in the US. is 5 years. Many factors are considered while on the waiting list, including body size, blood type, donor distance, and disease severity. Thus, the challenge of meeting unmet demand is forcing manufacturers to develop wearable bio-lungs, artificial pancreas and artificial kidneys. Artificial organs include devices such as artificial hearts, kidneys, livers, intestines, and lungs that replace or complement natural organs. This category is important because of organ failure due to chronic diseases, due to injuries or age-related circumstances. These are among the most important contributors to the kidney prosthesis stage. For example, SynCardia Systems’ Total Artificial Heart provides a life-saving solution for patients waiting for a heart transplant.
The artificial bionics segment is expected to grow at the fastest CAGR of 10.7% during the forecast period from 2024 to 2031. The major factors contributing to the growth of the segment are increasing demand for cochlear implants, vision, exoskeleton, limb, brain bionics fueling the market growth for prosthetics and bionics. For example, in January 2022, Cochlear Limited’s cochlear nucleus implants received approval from the US. the Food and Drug Administration to treat unilateral hearing loss and unilateral deafness. Artificial bionics refers to advanced bionic devices that not only recreate the physical structure of human organs or body parts but also enhance the sensitivity or function of those organs. This segment targets individuals in need of a prosthetic device that performs well, allowing for greater mobility and quality of life.
Key Trends Driving Market Growth
Global urbanization and rapid industrialization have increased the need for new market Growth. This has prompted a rise in the use of artificial organs. Additionally, massive amounts of money are being spent by governments and the private sector globally on artificial organs industry, which is further boosting the market’s expansion. The amount that regional governments are investing to improve the current investment is increasing as part of their global market plans.
Competitive landscaping:
To understand the competitive landscape, we are analyzing key artificial organs market vendors in the market. To understand the competitive rivalry, we are comparing the revenue, expenses, resources, product portfolio, region coverage, market share, key initiatives, product launches, and any news related to the artificial organs market.
Top Player’s Company Profiles
Edwards Lifesciences Corporation
Cochlear Limited
Zimmer Biomet Holding Inc.
Jarvik Heart, Inc.
Boston Scientific Corporation
Berlin Heart GmbH
SynCardia Systems LLC
CARMAT
BiVACOR Inc.
AWAK Technologies
Wearable Artificial Organs, Inc.
Medtronic Plc
ALung Technologies, Inc.
Fresenius Medical Care
Johnson & Johnson
TransMedics, Inc
Abott
Take Action Now: Secure your artificial organs industry today – https://www.skyquestt.com/buy-now/artificial-organs-market
FAQs:-
1. What are the sales, production, consumption, imports, and exports of the global market (North America, Europe, Asia-Pacific, South America, Middle East, and Africa)?
2. Who are the major manufacturers who dominate the artificial organs market?
3. What are their current capacity, production, sales, pricing, cost, gross, and revenue operating levels?
4. What are the market’s risks and opportunities?
As mentioned by the group of researchers and industry analysts, the report on the global market delivers some measurable insights related to artificial organs market. Furthermore, with the support of several business-driven strategies, the market report elaborates the shifting industrial scenarios. Crucial segments are ranked and segregated based on their industry shares in the global market. Moreover, the global artificial organs market research study briefly summarizes various key competition variables that are critical for the industry to determine possible market conditions at the global and regional level. The market report has been widely exhibited in order to deliver specialized industry assessment into the company profiles of the topmost players as well as highly established companies. Therefore, the artificial organs market has been evaluated as one of the helpful and extraordinary documents for the new entrants and industry players.
Above all, what criteria distinguish success from failure? We identified key parameters based on global market, which include pricing, value, availability, features, financing, upgrades or return policies, and customer service. Most importantly, this market study can assist you in identifying market blind spots.
Browse More Research –
Battery Energy Storage System Market – https://www.skyquestt.com/report/battery-energy-storage-system-market
About Us:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Us
Skyquest Technology Group
International: (+1) 351-333-4748
Email: [email protected]
